Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Feb 16;12:628966. doi: 10.3389/fimmu.2021.628966

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 Zhang, He, Dai, Wang, Liang, He, Xia, Feng, Cao, Zhang and Cheng

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Kaplan-Meier survival curves comparing high and low expression of PDIA5 in different cancers. OS of bladder urothelial carcinoma (BLCA) (A), cervical and endocervical cancers (CESC) (B), kidney renal papillary cell carcinoma (KIRP) (C), lung squamous cell carcinoma (LUSC) (D), mesothelioma (MESO) (E), and thyroid carcinoma (THCA) (F). Correlation of PDIA5 expression with OS (G) and DSS (H) in 33 types of cancer. OS, overall survival. DSS; disease specific survival. (I) Kaplan-Meier analysis of OS based on high vs. low expression of PDIA5 in pan-glioma, LGG, and GBM patients in the TCGA dataset. Red curve represents patients with high expression of PDIA5, and blue curve represents low PDIA5.